Zhu Y - Search Results

1

Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5⁺ CD8⁺ T cell abundance.

Huang Q, Zhou Q, Zhang H, Liu Z, Zeng H, Chen Y, Qu Y, Xiong Y, Wang J, Chang Y, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Wang Z, Bai Q, Zhang W. Huang Q, et al. Among authors: zhu y. Oncoimmunology. 2020 Aug 28;9(1):1810489. doi: 10.1080/2162402X.2020.1810489. Oncoimmunology. 2020. PMID: 32939328 Free PMC article.

2

Analysis of energy utilization and body composition in kidney, bladder, and adrenal cancer patients.

Xu WP, Cao DX, Lin ZM, Wu GH, Chen L, Zhang JP, Zhang B, Yang ZA, Jiang Y, Han YS, Xu L, Zhu Y, Chen WF. Xu WP, et al. Among authors: zhu y. Urol Oncol. 2012 Sep;30(5):711-8. doi: 10.1016/j.urolonc.2010.07.017. Epub 2010 Oct 2. Urol Oncol. 2012. PMID: 20884257

3

Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling.

Xu L, Zhu Y, Xu J, Wu K, Li J, Xu W, Liu H, Wang S, Yin H, Chen L, Wang G, Lin Z. Xu L, et al. Among authors: zhu y. Cancer Sci. 2012 Jul;103(7):1253-8. doi: 10.1111/j.1349-7006.2012.02291.x. Epub 2012 May 10. Cancer Sci. 2012. PMID: 22463491 Free PMC article.

4

Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma.

Xu L, Zhu Y, Chen L, An H, Zhang W, Wang G, Lin Z, Xu J. Xu L, et al. Among authors: zhu y. Ann Surg Oncol. 2014 Sep;21(9):3142-50. doi: 10.1245/s10434-014-3601-1. Epub 2014 Mar 11. Ann Surg Oncol. 2014. PMID: 24615178

5

Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma.

Liu W, Liu H, Liu Y, Xu L, Zhang W, Zhu Y, Xu J, Gu J. Liu W, et al. Among authors: zhu y. Ann Surg Oncol. 2014 Dec;21 Suppl 4:S575-83. doi: 10.1245/s10434-014-3680-z. Epub 2014 Apr 9. Ann Surg Oncol. 2014. PMID: 24715215

6

GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.

Liu Y, Liu W, Xu L, Liu H, Zhang W, Zhu Y, Xu J, Gu J. Liu Y, et al. Among authors: zhu y. J Urol. 2014 Nov;192(5):1534-41. doi: 10.1016/j.juro.2014.04.084. Epub 2014 Apr 21. J Urol. 2014. PMID: 24769034

7

Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma.

Lv T, Liu Y, Zhang J, Xu L, Zhu Y, Yin H, An H, Lin Z, Xie Y, Chen L. Lv T, et al. Among authors: zhu y. PLoS One. 2014 May 5;9(5):e95996. doi: 10.1371/journal.pone.0095996. eCollection 2014. PLoS One. 2014. PMID: 24797520 Free PMC article. Clinical Trial.

8

Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.

Fu Q, Liu Z, Pan D, Zhang W, Xu L, Zhu Y, Liu H, Xu J. Fu Q, et al. Among authors: zhu y. Cancer Sci. 2014 Nov;105(11):1427-34. doi: 10.1111/cas.12507. Epub 2014 Sep 23. Cancer Sci. 2014. PMID: 25155155 Free PMC article.

9

Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival.

Xu L, Zhu Y, An H, Liu Y, Lin Z, Wang G, Xu J. Xu L, et al. Among authors: zhu y. Urol Oncol. 2015 Feb;33(2):68.e9-16. doi: 10.1016/j.urolonc.2014.08.008. Epub 2014 Sep 18. Urol Oncol. 2015. PMID: 25241276

10

Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.

Pan D, Xu L, Liu H, Zhang W, Zhu Y, Xu J, Gu J. Pan D, et al. Among authors: zhu y. Jpn J Clin Oncol. 2015 Feb;45(2):202-9. doi: 10.1093/jjco/hyu194. Epub 2014 Nov 23. Jpn J Clin Oncol. 2015. PMID: 25420690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,063 results

Search Page

Filters